Are plant-based APIs the future of pharma and nutraceuticals

April 03, 2025

Remove from favorites

Add to favorites

The article explores the growing market for plant-based active pharmaceutical ingredients (APIs) in the pharmaceutical and nutraceutical industries, driven by increased consumer demand for natural products. The market, valued at $30.08 billion in 2024, is projected to reach $52.08 billion by 2034. Key drivers include consumer preferences for organic ingredients, advances in extraction technologies, and regulatory support, especially in regions like the U.S., Germany, and China. Additionally, cannabis-based APIs are gaining traction due to their therapeutic potential and reduced side effects. Sustainability concerns also contribute to the shift towards plant-based alternatives, as these ingredients typically have a smaller environmental footprint compared to synthetics (Ghosh, Future Market Insights, 2025).